Legal Representation
Attorney
Karl M. Zielaznicki, Esq.
USPTO Deadlines
Next Deadline
1771 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2000-05-16)
Due Date
May 16, 2030
Grace Period Ends
November 16, 2030
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 23, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Feb 25, 2021 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Feb 25, 2021 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
| Feb 25, 2021 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Feb 22, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Nov 25, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Nov 16, 2020 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Jul 2, 2020 | CORV | 1 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED |
| Jul 1, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jul 1, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 1, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 1, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Jul 1, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 1, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| May 16, 2019 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Feb 4, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Feb 4, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 17, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jun 4, 2014 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| May 28, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Nov 22, 2010 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Nov 22, 2010 | 8PRT | O | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED |
| Nov 22, 2010 | 9G8P | O | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 |
| Nov 22, 2010 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Nov 16, 2010 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Nov 16, 2010 | 89AF | I | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
| May 19, 2007 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Mar 5, 2007 | FAXX | I | FAX RECEIVED |
| Mar 5, 2007 | I | PAPER RECEIVED | |
| Mar 5, 2007 | PR23 | I | RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15 |
| Sep 14, 2006 | PR23 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| Aug 9, 2006 | PLGL | A | ASSIGNED TO PARALEGAL |
| May 15, 2006 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| May 15, 2006 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
| Mar 31, 2006 | CFIT | O | CASE FILE IN TICRS |
| May 16, 2000 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jan 27, 2000 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jan 11, 2000 | CNEA | S | EXAMINERS AMENDMENT -WRITTEN |
| Nov 1, 1999 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 2, 1999 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 24, 1999 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Dec 21, 1998 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 6, 1998 | CNRT | S | NON-FINAL ACTION MAILED |
| Oct 28, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 27, 1998 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Oct 2, 1998 | IUAF | S | USE AMENDMENT FILED |
| Jun 23, 1998 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 31, 1998 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 27, 1998 | NPUB | O | NOTICE OF PUBLICATION |
| Jan 22, 1998 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of central nervous system disorders, attention deficit/hyperactivity disorders, [ cardiovascular disorders, ] blood disorders, [ cancer, ] gastroenterological disorders, metabolic diseases, [ orthostatic hypotension, ] moderate to moderately severe pain [, and nausea ]
First Use Anywhere:
Jan 29, 1999
First Use in Commerce:
Jan 29, 1999
Class 042
[ providing laboratory services in connection with pharmaceutical preparations for treatment of human illnesses developed by applicant or its affiliates ]
First Use Anywhere:
Jun 5, 1998
First Use in Commerce:
Jun 5, 1998
Classification
International Classes
005
042